These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19675671)

  • 41. Evaluation of Soluble Human Leukocyte Antigen-G (sHLA-G) Isoforms and Regulatory T Cells in Relapsing-Remitting Multiple Sclerosis.
    Alsahebfosoul F; Zavaran Hosseini A; Salehi R; Etemadifar M; Esmaeil N; Jamshidian A
    Iran J Allergy Asthma Immunol; 2015 Jun; 14(3):298-305. PubMed ID: 26546899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis.
    Lin R; Taylor BV; Simpson S; Charlesworth J; Ponsonby AL; Pittas F; Dwyer T; van der Mei IA
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):399-404. PubMed ID: 23868949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum 25-Hydroxyvitamin D Level Is Not Related to Regulatory T Cells or Kidney Function in Renal Transplant Recipients.
    Myszka M; Mazanowska O; Kościelska-Kasprzak K; Bartoszek D; Żabińska M; Klinger M
    Transplant Proc; 2018; 50(6):1802-1806. PubMed ID: 30056904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens.
    Rodi M; Dimisianos N; de Lastic AL; Sakellaraki P; Deraos G; Matsoukas J; Papathanasopoulos P; Mouzaki A
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27571060
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulating effects of WT1 on interferon-β-vitamin D association in MS.
    Lin R; Taylor BV; Charlesworth J; van der Mei I; Blizzard L; Stewart N; Ponsonby AL; Dwyer T; Pittas F; Simpson S
    Acta Neurol Scand; 2015 Apr; 131(4):231-9. PubMed ID: 25312909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients.
    Álvarez-Sánchez N; Cruz-Chamorro I; Díaz-Sánchez M; Lardone PJ; Guerrero JM; Carrillo-Vico A
    Sci Rep; 2019 Feb; 9(1):2302. PubMed ID: 30783191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
    Nejati A; Shoja Z; Shahmahmoodi S; Tafakhori A; Mollaei-Kandelous Y; Rezaei F; Hamid KM; Mirshafiey A; Doosti R; Sahraian MA; Mahmoudi M; Shokri F; Emery V; Marashi SM
    Med Microbiol Immunol; 2016 Apr; 205(2):143-54. PubMed ID: 26365612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lower 25-Hydroxyvitamin D Is Associated with Higher Relapse Risk in Patients with Relapsing-Remitting Multiple Sclerosis.
    Wang C; Zeng Z; Wang B; Guo S
    J Nutr Health Aging; 2018; 22(1):38-43. PubMed ID: 29300420
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study.
    Simpson S; Stewart N; van der Mei I; Otahal P; Charlesworth J; Ponsonby AL; Blizzard L; Dwyer T; Pittas F; Gies P; Taylor B
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):200-7. PubMed ID: 24790215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone metabolism and vitamin D status in patients with multiple sclerosis.
    Kępczyńska K; Zajda M; Lewandowski Z; Przedlacki J; Zakrzewska-Pniewska B
    Neurol Neurochir Pol; 2016; 50(4):251-7. PubMed ID: 27375138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impaired regulatory T-cell homeostasis due to vitamin D deficiency in undifferentiated connective tissue disease.
    Zold E; Szodoray P; Kappelmayer J; Gaal J; Csathy L; Barath S; Gyimesi E; Hajas A; Zeher M; Szegedi G; Bodolay E
    Scand J Rheumatol; 2010 Nov; 39(6):490-7. PubMed ID: 20615161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy.
    Chiarini M; Serana F; Zanotti C; Capra R; Rasia S; Rottoli M; Rovaris M; Caputo D; Cavaletti G; Frigo M; Frigeni B; Clerici R; Rezzonico M; Caimi L; Imberti L
    Mult Scler; 2012 Jun; 18(6):788-98. PubMed ID: 22086901
    [TBL] [Abstract][Full Text] [Related]  

  • 55. GM-CSF production by CD4+ T cells in MS patients: regulation by regulatory T cells and vitamin D.
    Peelen E; Muris AH; Damoiseaux J; Knippenberg S; Broens K; Smolders J; Cohen Tervaert JW; Hupperts R; Thewissen M
    J Neuroimmunol; 2015 Mar; 280():36-42. PubMed ID: 25773153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Basal vitamin D levels and disease activity in multiple sclerosis patients treated with fingolimod.
    Ferre' L; Clarelli F; Sferruzza G; Rocca MA; Mascia E; Radaelli M; Sangalli F; Dalla Costa G; Moiola L; Aboulwafa M; Martinelli Boneschi F; Comi G; Filippi M; Martinelli V; Esposito F
    Neurol Sci; 2018 Aug; 39(8):1467-1470. PubMed ID: 29756179
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis.
    Ahmadian-Elmi M; Bidmeshki Pour A; Naghavian R; Ghaedi K; Tanhaei S; Izadi T; Nasr-Esfahani MH
    Immunogenetics; 2016 Jan; 68(1):43-54. PubMed ID: 26563334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered frequency of T regulatory cells is associated with disability status in relapsing-remitting multiple sclerosis patients.
    Bjerg L; Brosbøl-Ravnborg A; Tørring C; Dige A; Bundgaard B; Petersen T; Höllsberg P
    J Neuroimmunol; 2012 Aug; 249(1-2):76-82. PubMed ID: 22608884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. T regulatory cells lacking CD25 are increased in MS during relapse.
    Fransson M; Burman J; Lindqvist C; Atterby C; Fagius J; Loskog A
    Autoimmunity; 2010 Dec; 43(8):590-7. PubMed ID: 20370571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigating the roles of regulatory T cells, mast cells and interleukin-9 in the control of skin inflammation by vitamin D.
    Gorman S; Geldenhuys S; Weeden CE; Grimbaldeston MA; Hart PH
    Arch Dermatol Res; 2018 Apr; 310(3):221-230. PubMed ID: 29392411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.